Celanese Corp.

As of September 8, 2025, Celanese Corp. is in a bearish trend with weak strength, indicated by negative MACD readings and underperformance against the S&P 500, showing a year-to-date return of -34.29% compared to the S&P's 12.22%.

As of February 18, 2025, Celanese Corp. is considered risky and overvalued due to its high EV/EBITDA ratio of 11.97, negative ROE of -1.64%, and significantly higher P/E ratio of 144.70 compared to peers, alongside poor stock performance with a year-to-date return of -34.29% versus the S&P 500's 12.22%.

As of February 18, 2025, Celanese Corp. is considered risky and overvalued with a Price to Book Value of 1.82 and negative ROE of -1.64%, contrasting sharply with peers like Linde Plc and Ecolab, while its year-to-date return of -21.11% significantly underperforms the S&P 500's gain of 2.44%.

As of June 17, 2025, Celanese Corp. shows a mildly bearish trend with mixed technical indicators, including mildly bearish daily moving averages and a bearish monthly MACD, suggesting a cautious outlook.

As of March 2022, the management team of Celanese Corp. includes Ms. Lori Ryerkerk (Chairman, President, CEO), Mr. Edward Galante (Lead Independent Director), and several independent directors: Ms. Deborah Kissire, Ms. Jean Blackwell, Mr. William Brown, and Ms. Kathryn Hill. They guide the company's strategic direction and oversee operations.

Celanese Corporation is a technology and specialty materials company in the specialty chemicals industry, with a market cap of approximately $9.26 billion. As of March 2025, it reported net sales of $2.39 billion and a net profit of -$12 million.

As of Jun 18, Celanese Corp. has a market capitalization of 9,258.74 million and reported net sales of 10,058.00 million with a net profit loss of 1,642.00 million for the latest four quarters. As of Dec 24, the company has shareholder's funds of 5,175.00 million and total assets of 22,857.00 million.